Jensen, Esben Skov
Olesen, Kevin Kris Warnakula
Gyldenkerne, Christine
Thrane, Pernille Gro
Jensen, Lisette Okkels
Raungaard, Bent
Poulsen, Per Løgstrup
Thomsen, Reimar Wernich
Maeng, Michael https://orcid.org/0000-0002-4310-6433
Article History
Received: 21 June 2021
Accepted: 8 October 2021
First Online: 4 December 2021
Declarations
:
: This study was approved by the Danish Data Protection Agency (record no. 1-16-02-193-18). According to Danish regulations, observational non-interventional registry-based studies do not require approval from ethics committees or informed consent from participants.
: Informed consent is not required from participants in registry-based, non-interventional cohort studies according to Danish regulation.
: The authors declare that they have no competing interests. Department of Clinical Epidemiology is, however, involved in studies with funding from various companies as research grants to and administered by Aarhus University. None of these studies are related to the current study. Dr. Maeng has received advisory board fees from Boehringer-Ingelheim, AstraZeneca, Novo Nordisk, BMS, Boston Scientific, and Bayer.